Nathan J. Dowden, Chief Operating Officer at Entrada Therapeutics, Inc. (TRDA), sold 2,100 shares at $24.05 ($51K) on 2022-10-31, disclosed to the SEC on 2022-11-02.
Open-market sale of $51k TRDA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |